| Gastrointestinal dysfunctions in Parkinson's disease: symptoms and treatments | 8,672 |
| Pathophysiology of motor dysfunction in Parkinson's disease as the rationale for drug treatment and rehabilitation | 7,067 |
| DBS Programming: an evolving approach for patients with Parkinson's disease | 4,308 |
| LSVT LOUD and LSVT BIG: Behavioral Treatment Programs for Speech and Body Movement in Parkinson disease | 4,088 |
| Progressive resistance exercise and Parkinson's disease: A review of potential mechanisms | 2,815 |
| Living with Parkinson's, the emerging role of occupational therapy. | 2,722 |
| N-Acetyl Cysteine Protects against Methamphetamine-induced Dopaminergic Neurodegeneration via Modulation of Redox Status and Autophagy in Dopaminergic cells | 2,635 |
| Comparing the Mini-BESTest with the Berg Balance Scale to Evaluate Balance Disorders in Parkinson's Disease | 2,503 |
| METHAMPHETAMINE AND PARKINSON´S DISEASE | 2,401 |
| A cognitive-perceptual approach to conceptualizing speech intelligibility deficits and remediation practice in hypokinetic dysarthria | 1,811 |
